Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8 USD | -23,08% | -1,89% | -1,23% |
Omzet 2024 * | 55,47 mln. 51,14 mln. | Omzet 2025 * | 11,82 mln. 10,9 mln. | Marktkapitalisatie | 79,16 mln. 72,99 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -46 mln. -42,42 mln. | Nettowinst (verlies) 2025 * | -102 mln. -94,05 mln. | EV/omzet 2024 * | 1,43 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 6,7 x |
K/w-verhouding 2024 * |
-2,58
x | K/w-verhouding 2025 * |
-1,27
x | Werknemers | 165 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 78,47% |
Recentste transcriptie over HOOKIPA Pharma Inc.
1 dag | -23,08% | ||
1 week | -1,89% | ||
Lopende maand | -9,84% | ||
1 maand | -5,88% | ||
3 maanden | +24,98% | ||
6 maanden | +59,05% | ||
Lopend jaar | -1,23% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 01-06-16 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 01-04-17 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-02-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 01-06-16 |
Chairman | 63 | 01-10-17 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 01-04-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 0,8 | -23,08% | 2 266 103 |
23-05-24 | 1,04 | +6,12% | 1 652 899 |
22-05-24 | 0,98 | +14,34% | 2 167 001 |
21-05-24 | 0,8571 | -0,22% | 567 738 |
20-05-24 | 0,859 | +5,35% | 451 551 |
uitgestelde koers Nasdaq, 24 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,23% | 103 mln. | |
+38,51% | 728 mld. | |
+33,05% | 603 mld. | |
-6,23% | 360 mld. | |
+18,78% | 332 mld. | |
+1,35% | 279 mld. | |
+16,00% | 244 mld. | |
+8,09% | 207 mld. | |
-5,77% | 205 mld. | |
+6,19% | 164 mld. |